Skip to content

About
News
Clinicians
Patients
Research

About
News
Clinicians
Patients
Research

Retina Publications

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry

Ophthalmology Retina

September 2020

Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration

Retina

September 2020

Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! Registry

Clinical and Experimental Ophthalmology

August 2020

Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project

British Journal of Ophthalmology

August 2020

Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study

Clinical and Experimental Ophthalmology

July 2020

Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!

Journal Français d’Ophtalmologie

July 2020

Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry

Ophthalmology

May 2020

Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry

Clinical and Experimental Ophthalmology

May 2020

Assessing the accuracy of a large observational registry of neovascular age-related macular degeneration

Retina

May 2020

Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry

Ophthalmology

March 2020

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions

American Journal of Ophthalmology

February 2020

Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months

British Journal of Ophthalmology

September 2019

« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Next »

Email: ssi.ssr@sydney.edu.au
Phone: (+61) 421 787 808

Level 1, South Block
Sydney Eye Hospital
8 Macquarie Street
Sydney NSW 2000

Follow us

X-twitter Facebook Youtube

Quick links

Contact Us
Donate Now

Contact Us
Donate Now